Barry Flannelly
Director/Board Member at PROTARA THERAPEUTICS, INC.
Net worth: 4 M $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jesse Shefferman | M | 52 | 7 years | |
Julian Baker | M | 57 | 23 years | |
Richard Levy | M | 66 | 19 years | |
Herve Hoppenot | M | 64 | 10 years | |
Luke Beshar | M | 65 | 6 years | |
Jacqueline Zummo | M | 43 | 7 years | |
Edmund Harrigan | M | 71 | 5 years | |
Hannah Fry | F | 34 | 4 years | |
Mary J. Grendell | F | - | - | |
Thomas Tray | M | 46 | 19 years | |
Jane Huang | M | 51 | 3 years | |
Justine O'Malley | M | - | 4 years | |
Katherine High | M | 72 | 4 years | |
Cynthia Smith | F | 55 | 3 years | |
Susanne Antonie Schaffert | M | 57 | 2 years | |
Paul Clancy | M | 62 | 9 years | |
Jean-Jacques Bienaimé | M | 70 | 9 years | |
Pablo Cagnoni | M | 60 | 1 years | |
Gregory Sargen | M | 58 | 5 years | |
Roger Garceau | M | 70 | 5 years | |
Otis Brawley | M | 64 | 3 years | |
Jacqualyn Fouse | M | 62 | 7 years | |
Sheila Denton | F | 58 | 1 years | |
Michael Solomon | M | 54 | 6 years | |
Christiana Stamoulis | F | 53 | 5 years | |
Denise Brashear | F | - | 2 years | |
Benjamin J. Strain | M | - | 1 years | |
Patrick Fabbio | M | 56 | 1 years | |
Kevin Conroy | M | 58 | 5 years | |
Lothar H. Finke | M | - | 7 years | |
Peter Langmuir | M | - | 9 years | |
Keith Mikkelson | M | - | 22 years | |
Vijay Iyengar | M | 51 | 8 years | |
Jeffrey Elliott | M | 46 | 5 years | |
Catalina Loveman | F | - | 9 years | |
Steven Stein | M | 57 | 9 years | |
Paula Swain | F | 66 | 22 years | |
Michael Morrissey | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kim Popovits | F | 65 | 17 years | |
Paul Friedman | M | 81 | 20 years | |
Henry Fuchs | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 10 years |
Felix Baker | M | 55 | 7 years | |
Andrew Hindman | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
Ashley Garry | M | - | 1 years | |
Jason W. Radford | M | 42 | 4 years | |
Geoffrey Parker | M | 59 | 3 years | |
Reid Huber | M | 52 | 16 years | |
Blaine Davis | M | 50 | 2 years | |
Wendy Dixon | M | 68 | 12 years | |
James J. Vaughn | M | 61 | - | |
Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Bryant Lim | M | 53 | 4 years | |
Paul Trower | M | 54 | 18 years | |
Maria Pasquale | F | 58 | 5 years | |
Michael Charles A. Booth | M | 53 | 7 years | |
Krishna Vaddi | M | 58 | 13 years | |
Fred Cohen | M | 67 | 17 years | |
David Hastings | M | 62 | 11 years | |
Andrew Combs | M | 58 | 16 years | |
Suzanne M. Shema | F | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
Richard de Schutter | M | 83 | 12 years | |
Barry Michael Ariko | M | 78 | 14 years | |
Paul Brooke | M | 77 | 19 years | |
Steven Shak | M | 73 | 19 years | |
Jathin Bandari | M | 37 | 4 years | |
Michael Wolfe | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Scott Barrett | M | 61 | 3 years | |
Dashyant Dhanak | M | 61 | - | |
Michael Purvis | M | - | 6 years | |
Frederick Baehner | M | - | - | |
Kevin N. Heller | M | 53 | 3 years | |
David Hanlon | M | - | - | |
Dave Green | M | - | - | |
Kevin Harris | M | 53 | 10 years | |
Cheng Bonnie | F | - | - | |
Michael Howell | M | 47 | 4 years | |
Conrad Jordaan | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
Jay Newmark | M | - | 1 years | |
Richard Bryce | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Natalie Sacks | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
Julio Casoy | M | 72 | 1 years | |
D. Coward | M | 59 | - | |
Gregory W. Schafer | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
David Gryska | M | 68 | 4 years | |
Ted Love | M | 65 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
Michael Kauffman | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 years |
Matthew Fust | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Kim McEachron | F | 68 | 7 years | |
Yujiro Hata | M | 49 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
Christine K. Chiou | F | - | 4 years | |
Lucio Tozzi | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Robert Newton | M | - | 5 years | |
Lori Murray | F | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 6 years |
Barbara Klencke | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
Jon Cassel | M | - | 12 years | |
Victor Sandor | M | 57 | 9 years | |
Todd Edwards | M | 61 | - | |
Peggy Scherle | M | 62 | 16 years | |
Joseph Leveque | M | 63 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
Kristy Rosse | F | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry Flannelly
- Personal Network